Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fons A J van de Loo

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Opinion in Molecular Therapeutics|November 13, 2004
Inflammation-responsive promoters for fine-tuned gene therapy in rheumatoid arthritisFons A J van de Loo
Arthritis Research & Therapy|May 6, 2011
Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?Fons A J van de Loo
Nutrition (Burbank, Los Angeles County, Calif.)|October 27, 2019
Osteoporosis and osteoarthritis are two sides of the same coin paid for obesityMarina C Oliveira, Julia Vullings, Fons A J van de Loo
Rheumatic Diseases Clinics of North America|February 14, 2002
Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulatorsFons A J van de Loo, Wim B van den Berg
Pharmacology & Therapeutics|May 16, 2021
Resolving inflammation by TAM receptor activationJuliana P Vago, Flávio A Amaral, Fons A J van de Loo
Rheumatology (Oxford, England)|July 22, 2020
A roadmap to target interleukin-6 in osteoarthritisRenske Wiegertjes, Fons A J van de Loo, Esmeralda N Blaney Davidson
Current Rheumatology Reports|September 16, 2006
Gene therapy works in animal models of rheumatoid arthritis...so what!Fons A J van de Loo, Jeroen Geurts, Wim B van den Berg
Arthritis Research & Therapy|May 6, 2011
Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synoviumShahla Abdollahi-Roodsaz, Fons A J van de Loo, Wim B van den Berg
Arthritis Research & Therapy|September 24, 2004
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?Fons A J van de Loo, Ruben L Smeets, Wim B van den Berg
Biomaterials|December 31, 2003
Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal modelsPeter M van der Kraan, Fons A J van de Loo, Wim B van den Berg
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Opinion in Molecular Therapeutics|November 13, 2004
Inflammation-responsive promoters for fine-tuned gene therapy in rheumatoid arthritisFons A J van de Loo
Arthritis Research & Therapy|May 6, 2011
Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?Fons A J van de Loo
Nutrition (Burbank, Los Angeles County, Calif.)|October 27, 2019
Osteoporosis and osteoarthritis are two sides of the same coin paid for obesityMarina C Oliveira, Julia Vullings, Fons A J van de Loo
Rheumatic Diseases Clinics of North America|February 14, 2002
Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulatorsFons A J van de Loo, Wim B van den Berg
Pharmacology & Therapeutics|May 16, 2021
Resolving inflammation by TAM receptor activationJuliana P Vago, Flávio A Amaral, Fons A J van de Loo
Rheumatology (Oxford, England)|July 22, 2020
A roadmap to target interleukin-6 in osteoarthritisRenske Wiegertjes, Fons A J van de Loo, Esmeralda N Blaney Davidson
Current Rheumatology Reports|September 16, 2006
Gene therapy works in animal models of rheumatoid arthritis...so what!Fons A J van de Loo, Jeroen Geurts, Wim B van den Berg
Arthritis Research & Therapy|May 6, 2011
Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synoviumShahla Abdollahi-Roodsaz, Fons A J van de Loo, Wim B van den Berg
Arthritis Research & Therapy|September 24, 2004
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?Fons A J van de Loo, Ruben L Smeets, Wim B van den Berg
Biomaterials|December 31, 2003
Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal modelsPeter M van der Kraan, Fons A J van de Loo, Wim B van den Berg
Pageof 11